Global Vaccines Market

- Size, Trend, Share, Opportunity Analysis & Forecast, 2014-2025

  • Date March 2017
  • price $3619
 
 

Vaccines Market Overview

Global Vaccines Market is expected to grow at a CAGR of 9.8% from 2017 to 2025. Vaccines are the products that provide acquired immunity against a particular disease. Vaccines consist of killed or modified microbes, parts of microbes, or microbial DNA that make the body think that an infection has occurred. A vaccinated persons immune system attacks the harmless vaccine and prepares the body to be immune against the kind of microbe the vaccine contained. 

Vaccines Market is divided based on product as conjugate vaccines, toxoid vaccines, recombinant vaccines, live attenuated vaccines, and inactivated & subunit vaccines. Based on type, the vaccines market is segmented as monovalent vaccines, and multivalent vaccines. According to application, the market is divided into polio, Measles, Mumps, and Rubella (MMR), Diphtheria, Pertussis, and Tetanus (DTP), hepatitis, pneumococcal disease, influenza, rotavirus, varicella, meningococcal disease, Human Papilloma Virus (HPV) infection, and others. Geographically, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

Vaccines Market Dynamics:

Drivers:

  • Increase in funding from government and private organizations for R&D of new vaccines.
  • Increase in incidence of diseases worldwide.
  • Increase in use of pediatric vaccines.

Restraints:

  • High capital investment for the development of vaccines.
  • Stringent governmental rules for approval of vaccines.

Vaccines Market Players:

The top players in the global vaccines market include Astellas Pharma Inc., Emergent BioSolutions, Inc., CSL Limited, GlaxoSmithKline, plc., Johnson & Johnson Pvt. Ltd., MedImmune, LLC, Merck & Co., Pfizer, Inc., Serum Institute of India Pvt. Ltd., and Sanofi Pasteur. Market players for global vaccines market adopt different strategies such as product development, product approval, acquisition, and collaboration to keep pace with the evolving market trends.

KEY TAKEAWAYS
Global Vaccines Market

MARKET LANDSCAPE

By Product

  • Conjugate Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Live Attenuated Vaccines
  • Inactivated and Subunit Vaccines

By Type

  • Monovalent vaccines
  • Multivalent vaccines

By Application

  • Polio
  • Measles, Mumps, and Rubella (MMR)
  • Diphtheria, Pertussis, and Tetanus (DTP)
  • Hepatitis
  • Pneumococcal Disease
  • Influenza
  • Rotavirus
  • Varicella
  • Meningococcal Disease
  • Human Papilloma Virus (HPV) infection
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
1. Executive summary
1.1. Key findings
1.2. Market attractiveness and trend analysis
1.3. Competitive landscape and recent industry development analysis
2. Introduction
2.1. Report description
2.2. Scope and definitions
2.3. Research methodology
3. Market landscape
3.1. Growth drivers
3.1.1. Impact analysis
3.2. Restrains and challenges
3.2.1. Impact analysis
3.3. Porter’s analysis
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Industry rivalry
3.3.5. Threat of new entrants
3.4. Global vaccines market shares analysis, 2014-2025
3.4.1. Global vaccines market share by product, 2014-2025
3.4.2. Global vaccines market share by type, 2014-2025
3.4.3. Global vaccines market share by application, 2014-2025
3.4.4. Global vaccines market share by geography, 2014-2025
4. Global vaccines market by product
4.1. Conjugate vaccines
4.1.1. Historical market size by region, 2014-2016
4.1.2. Market forecast by region, 2017-2025
4.2. Toxoid vaccines
4.2.1. Historical market size by region, 2014-2016
4.2.2. Market forecast by region, 2017-2025
4.3. Recombinant vaccines
4.3.1. Historical market size by region, 2014-2016
4.3.2. Market forecast by region, 2017-2025
4.4. Live attenuated vaccines
4.4.1. Historical market size by region, 2014-2016
4.4.2. Market forecast by region, 2017-2025
4.5. Inactivated and subunit vaccines
4.5.1. Historical market size by region, 2014-2016
4.5.2. Market forecast by region, 2017-2025
5. Global vaccines market by type
5.1. Monovalent vaccines
5.1.1. Historical market size by region, 2014-2016
5.1.2. Market forecast by region, 2017-2025
5.2. Multivalent vaccines
5.2.1. Historical market size by region, 2014-2016
5.2.2. Market forecast by region, 2017-2025
6. Global vaccines market by application
6.1. Polio
6.1.1. Historical market size by region, 2014-2016
6.1.2. Market forecast by region, 2017-2025
6.2. Measles, mumps, and rubella (mmr)
6.2.1. Historical market size by region, 2014-2016
6.2.2. Market forecast by region, 2017-2025
6.3. Diphtheria, pertussis, and tetanus (dtp)
6.3.1. Historical market size by region, 2014-2016
6.3.2. Market forecast by region, 2017-2025
6.4. Hepatitis
6.4.1. Historical market size by region, 2014-2016
6.4.2. Market forecast by region, 2017-2025
6.5. Pneumococcal disease
6.5.1. Historical market size by region, 2014-2016
6.5.2. Market forecast by region, 2017-2025
6.6. Influenza
6.6.1. Historical market size by region, 2014-2016
6.6.2. Market forecast by region, 2017-2025
6.7. Rotavirus
6.7.1. Historical market size by region, 2014-2016
6.7.2. Market forecast by region, 2017-2025
6.8. Varicella
6.8.1. Historical market size by region, 2014-2016
6.8.2. Market forecast by region, 2017-2025
6.9. Meningococcal disease
6.9.1. Historical market size by region, 2014-2016
6.9.2. Market forecast by region, 2017-2025
6.10. Meningococcal disease
6.10.1. Historical market size by region, 2014-2016
6.10.2. Market forecast by region, 2017-2025
6.11. Human papilloma virus (hpv) infection
6.11.1. Historical market size by region, 2014-2016
6.11.2. Market forecast by region, 2017-2025
6.12. Others
6.12.1. Historical market size by region, 2014-2016
6.12.2. Market forecast by region, 2017-2025
7. Global vaccines market by geography
7.1. North America
7.1.1. U.S.
7.1.1.1. Historical market size, 2014-2016
7.1.1.2. Market forecast, 2017-2025
7.1.2. Canada
7.1.2.1. Historical market size, 2014-2016
7.1.2.2. Market forecast, 2017-2025
7.1.3. Mexico
7.1.3.1. Historical market size, 2014-2016
7.1.3.2. Market forecast, 2017-2025
7.2. Europe
7.2.1. UK
7.2.1.1. Historical market size, 2014-2016
7.2.1.2. Market forecast, 2017-2025
7.2.2. Germany
7.2.2.1. Historical market size, 2014-2016
7.2.2.2. Market forecast, 2017-2025
7.2.3. France
7.2.3.1. Historical market size, 2014-2016
7.2.3.2. Market forecast, 2017-2025
7.2.4. Spain
7.2.4.1. Historical market size, 2014-2016
7.2.4.2. Market forecast, 2017-2025
7.2.5. Italy
7.2.5.1. Historical market size, 2014-2016
7.2.5.2. Market forecast, 2017-2025
7.2.6. Rest of Europe
7.2.6.1. Historical market size, 2014-2016
7.2.6.2. Market forecast, 2017-2025
7.3. Asia-Pacific
7.3.1. China
7.3.1.1. Historical market size, 2014-2016
7.3.1.2. Market forecast, 2017-2025
7.3.2. Japan
7.3.2.1. Historical market size, 2014-2016
7.3.2.2. Market forecast, 2017-2025
7.3.3. India
7.3.3.1. Historical market size, 2014-2016
7.3.3.2. Market forecast, 2017-2025
7.3.4. Australia
7.3.4.1. Historical market size, 2014-2016
7.3.4.2. Market forecast, 2017-2025
7.3.5. South Korea
7.3.5.1. Historical market size, 2014-2016
7.3.5.2. Market forecast, 2017-2025
7.3.6. Rest of Asia-Pacific
7.3.6.1. Historical market size, 2014-2016
7.3.6.2. Market forecast, 2017-2025
7.4. LAMEA
7.4.1. Brazil
7.4.1.1. Historical market size, 2014-2016
7.4.1.2. Market forecast, 2017-2025
7.4.2. South Arabia
7.4.2.1. Historical market size, 2014-2016
7.4.2.2. Market forecast, 2017-2025
7.4.3. South Africa
7.4.3.1. Historical market size, 2014-2016
7.4.3.2. Market forecast, 2017-2025
7.4.4. Rest of LAMEA
7.4.4.1. Historical market size, 2014-2016
7.4.4.2. Market forecast, 2017-2025
8. Company profiles
8.1. Astellas pharma inc.
8.1.1. Overview
8.1.2. Financials and business segments
8.1.3. Recent developments
8.2. Emergent biosolutions, inc.
8.2.1. Overview
8.2.2. Financials and business segments
8.2.3. Recent developments
8.3. Csl limited
8.3.1. Overview
8.3.2. Financials and business segments
8.3.3. Recent developments
8.4. Glaxosmithkline, plc.
8.4.1. overview
8.4.2. Financials and business segments
8.4.3. Recent developments
8.5. Johnson & johnson
8.5.1. Overview
8.5.2. Financials and business segments
8.5.3. Recent developments
8.6. Medimmune, llc
8.6.1. Overview
8.6.2. Financials and business segments
8.6.3. Recent developments
8.7. Merck & co.
8.7.1. Overview
8.7.2. Financials and business segments
8.7.3. Recent developments
8.8. Pfizer, inc.
8.8.1. overview
8.8.2. Financials and business segments
8.8.3. Recent developments
8.9. Serum institute of india pvt. Ltd.
8.9.1. Overview
8.9.2. Financials and business segments
8.9.3. Recent developments
8.10. Sanofi pasteur
8.10.1. Overview
8.10.2. Financials and business segments
8.10.3. Recent developments

List of Tables
Table 1.Vaccines Market Share, by Product, 2014-2025
Table 2.Vaccines Market Share, by Type, 2014-2025
Table 3.Vaccines Market Share, by Application, 2014-2025
Table 4.Vaccines Market Share for , by Region, 2017-2025
Table 5.Vaccines Market Value for Conjugate Vaccines, by Region, 2017-2025, $million
Table 6.Vaccines Market Value for Toxoid Vaccines, by Region, 2017-2025, $million
Table 7.Vaccines Market Value for Recombinant Vaccines, by Region, 2017-2025, $million
Table 8.Vaccines Market Value for Live Attenuated Vaccines, by Region, 2017-2025, $million
Table 9.Vaccines Market Value for Inactivated and Subunit Vaccines, by Region, 2017-2025, $million
Table 10.Vaccines Market Value for Monovalent vaccines, by Region, 2017-2025, $million
Table 11.Vaccines Market Value for Multivalent vaccines, by Region, 2017-2025, $million
Table 12.Vaccines Market Value for Polio, by Region, 2017-2025, $million
Table 13.Vaccines Market Value for Measles, Mumps, and Rubella (MMR), by Region, 2017-2025, $million
Table 14.Vaccines Market Value for Diphtheria, Pertussis, and Tetanus (DTP), by Region, 2017-2025, $million
Table 15.Vaccines Market Value for Hepatitis , by Region, 2017-2025, $million
Table 16.Vaccines Market Value for Pneumococcal Disease, by Region, 2017-2025, $million
Table 17.Vaccines Market Value for Influenza, by Region, 2017-2025, $million
Table 18.Vaccines Market Value for Rotavirus, by Region, 2017-2025, $million
Table 19.Vaccines Market Value for Varicella, by Region, 2017-2025, $million
Table 20.Vaccines Market Value for Meningococcal Disease, by Region, 2017-2025, $million
Table 21.Vaccines Market Value for Human Papilloma Virus (HPV) infection, by Region, 2017-2025, $million
Table 22.Vaccines Market Value for Others, by Region, 2017-2025, $million
Table 23.Vaccines Market Value for North America, by Country, 2014-2025, $million
Table 24.Vaccines Market Value for North America, by Product, 2014-2025, $million
Table 25.Vaccines Market Value for North America, by Type, 2014-2025, $million
Table 26.Vaccines Market Value for North America, by Application, 2014-2025, $million
Table 27.Vaccines Market Value for Europe, by Country, 2014-2025, $million
Table 28.Vaccines Market Value for Europe, by Product, 2014-2025, $million
Table 29.Vaccines Market Value for Europe, by Type, 2014-2025, $million
Table 30.Vaccines Market Value for Europe, by Application, 2014-2025, $million
Table 31.Vaccines Market Value for Asia-Pacific, by Country, 2014-2025, $million
Table 32.Vaccines Market Value for Asia-Pacific, by Product, 2014-2025, $million
Table 33.Vaccines Market Value for Asia-Pacific, by Type, 2014-2025, $million
Table 34.Vaccines Market Value for Asia-Pacific, by Application, 2014-2025, $million
Table 35.Vaccines Market Value for LAMEA, by Country, 2014-2025, $million
Table 36.Vaccines Market Value for LAMEA, by Product, 2014-2025, $million
Table 37.Vaccines Market Value for LAMEA, by Type, 2014-2025, $million
Table 38.Vaccines Market Value for LAMEA, by Application, 2014-2025, $million
Table 39. Astellas Pharma Inc. - Company Snapshot
Table 40. Emergent BioSolutions, Inc. - Company Snapshot
Table 41. CSL Limited - Company Snapshot
Table 42. GlaxoSmithKline, plc. - Company Snapshot
Table 43. Johnson & Johnson - Company Snapshot
Table 44. MedImmune, LLC - Company Snapshot
Table 45. Merck & Co. - Company Snapshot
Table 46. Pfizer, Inc. - Company Snapshot
Table 47. Serum Institute of India Pvt. Ltd. - Company Snapshot
Table 48. Sanofi Pasteur - Company Snapshot

List of Figures
Figure 1.Vaccines: Conjugate Vaccines Market Value, 2014-2016, $million
Figure 2.Vaccines: Toxoid Vaccines Market Value, 2014-2016, $million
Figure 3.Vaccines: Recombinant Vaccines Market Value, 2014-2016, $million
Figure 4.Vaccines: Live Attenuated Vaccines Market Value, 2014-2016, $million
Figure 5.Vaccines: Inactivated and Subunit Vaccines Market Value, 2014-2016, $million
Figure 6.Vaccines: Monovalent vaccines Market Value, 2014-2016, $million
Figure 7.Vaccines: Multivalent vaccines Market Value, 2014-2016, $million
Figure 8.Vaccines: Polio Market Value, 2014-2016, $million
Figure 9.Vaccines: Measles, Mumps, and Rubella (MMR) Market Value, 2014-2016, $million
Figure 10.Vaccines: Diphtheria, Pertussis, and Tetanus (DTP) Market Value, 2014-2016, $million
Figure 11.Vaccines: Hepatitis Market Value, 2014-2016, $million
Figure 12.Vaccines: Pneumococcal Disease Market Value, 2014-2016, $million
Figure 13.Vaccines: Influenza Market Value, 2014-2016, $million
Figure 14.Vaccines: Rotavirus Market Value, 2014-2016, $million
Figure 15.Vaccines: Varicella Market Value, 2014-2016, $million
Figure 16.Vaccines: Meningococcal Disease Market Value, 2014-2016, $million
Figure 17.Vaccines: Human Papilloma Virus (HPV) infection Market Value, 2014-2016, $million
Figure 18.Vaccines: Others Market Value, 2014-2016, $million
Figure 19.Vaccines: U.S. Market Value, 2014-2016, $million
Figure 20.Vaccines: U.S. Market Value, 2017-2025, $million
Figure 21.Vaccines: Canada Market Value, 2014-2016, $million
Figure 22.Vaccines: Canada Market Value, 2017-2025, $million
Figure 23.Vaccines: Mexico Market Value, 2014-2016, $million
Figure 24.Vaccines: Mexico Market Value, 2017-2025, $million
Figure 25.Vaccines: UK Market Value, 2014-2016, $million
Figure 26.Vaccines: UK Market Value, 2017-2025, $million
Figure 27.Vaccines: Germany Market Value, 2014-2016, $million
Figure 28.Vaccines: Germany Market Value, 2017-2025, $million
Figure 29.Vaccines: France Market Value, 2014-2016, $million
Figure 30.Vaccines: France Market Value, 2017-2025, $million
Figure 31.Vaccines: Spain Market Value, 2014-2016, $million
Figure 32.Vaccines: Spain Market Value, 2017-2025, $million
Figure 33.Vaccines: Italy Market Value, 2014-2016, $million
Figure 34.Vaccines: Italy Market Value, 2017-2025, $million
Figure 35.Vaccines: Rest of Europe Market Value, 2014-2016, $million
Figure 36.Vaccines: Rest of Europe Market Value, 2017-2025, $million
Figure 37.Vaccines: China Market Value, 2014-2016, $million
Figure 38.Vaccines: China Market Value, 2017-2025, $million
Figure 39.Vaccines: Japan Market Value, 2014-2016, $million
Figure 40.Vaccines: Japan Market Value, 2017-2025, $million
Figure 41.Vaccines: India Market Value, 2014-2016, $million
Figure 42.Vaccines: India Market Value, 2017-2025, $million
Figure 43.Vaccines: Australia Market Value, 2014-2016, $million
Figure 44.Vaccines: Australia Market Value, 2017-2025, $million
Figure 45.Vaccines: South Korea Market Value, 2014-2016, $million
Figure 46.Vaccines: South Korea Market Value, 2017-2025, $million
Figure 47.Vaccines: Rest of Asia-Pacific Market Value, 2014-2016, $million
Figure 48.Vaccines: Rest of Asia-Pacific Market Value, 2017-2025, $million
Figure 49.Vaccines: Brazil Market Value, 2014-2016, $million
Figure 50.Vaccines: Brazil Market Value, 2017-2025, $million
Figure 51.Vaccines: Saudi Arabia Market Value, 2014-2016, $million
Figure 52.Vaccines: Saudi Arabia Market Value, 2017-2025, $million
Figure 53.Vaccines: South Africa Market Value, 2014-2016, $million
Figure 54.Vaccines: South Africa Market Value, 2017-2025, $million
Figure 55.Vaccines: Rest of LAMEA Market Value, 2014-2016, $million
Figure 56.Vaccines: Rest of LAMEA Market Value, 2017-2025, $million
License Type
Single User PDF
Enterprise Online /PDF
Price
User / Sharing
Restricted to one authorized user
Unlimited within company / enterprise
Printing
One Print only
Unlimited within company / enterprise
Delivery Formats
ADDED BENIFITS

20% Free customization (Pre-sale)

16 Analyst hour support (Post Sale)

40 Analyst hour support (Post Sale)

160 hours of mini-consult

Free quarterly industry update

Free report on update (within 180 days)

MULTIPLE PURCHASE

Complimentary report with 2 reports

Complimentary report with 3 reports

Subscription Model

 
 

Are You?

  • Startup
  • Student or University
  • Research Scholar
  • Government Agencies
  • Non-profit Organization
  • NGO / Self Help Group
  • First Time Buyer

Get Discount     btn-arrow

Please Select Format

Need More Information

Why Progressive Markets

The market research services provided by Progressive Markets are restricted to publications, which may also include insignificant market data. The services are for the internal use of customers only and they do not have any rights to utilize this data for general publications or/and disclosure to third parties. As data is gathered through research activities such as online surveys and interviews with industry experts, it may have variations and fluctuation due to constantly changing market conditions. Thus, Progressive Markets holds no responsibility for misleading or false information gathered from these sources.

Progressive Markets understands and respects the privacy of persona

Recently Viewed Reports

Similar Market Research Report

blog
Aug
2017
Global Silver Market

The global silver consumption accounted for 37,704 tons in 2016 and expected to reach 49,860 tons by 2022, growing at a CAGR of 4.6% from 2017 to 2022. Silver is ... Read More >>

 

Get Email Alert